Efficient colorectal cancer classification from histopathological images utilizing lightweight convolutional neural
Ali Raza1, Fareeha Hanif1, Heba Abdelgader Mohammed2
1College of Computer Science, KSUx Training Platform, King Saud University, Riyadh, Saudi Arabia.
Computers in Biology and Medicine
|June 9, 2026
Summary
Lightweight convolutional neural networks (CNNs) show promise for analyzing colon tissue images. However, their performance degrades on new datasets, highlighting the need for broader validation in colorectal cancer diagnosis.
Area of Science:
- Medical image analysis
- Computational pathology
- Artificial intelligence in oncology
Background:
- Colorectal cancer is a leading cause of cancer death globally.
- Accurate histopathological analysis is crucial for timely diagnosis and treatment decisions.
- Automated image analysis using deep learning offers potential for improved efficiency and accuracy.
Purpose of the Study:
- To evaluate lightweight convolutional neural network (CNN) variants for binary classification of colon histopathology images.
- To compare the accuracy-efficiency trade-offs of different CNN architectures.
- To assess model robustness against domain shift in colorectal cancer histopathology.
Main Methods:
- A unified framework with standardized preprocessing, data augmentation, and class-weighted optimization was used.
- Four lightweight CNN variants were trained and validated for classifying colon adenocarcinoma and benign tissue.
- Model performance was analyzed using learning curves, confusion matrices, ROC, and precision-recall diagnostics.
Main Results:
- Lite-V2 demonstrated the best accuracy-efficiency trade-off on in-domain validation, with a small footprint and stable convergence.
- Significant performance degradation was observed on independent test sets and external datasets, indicating sensitivity to domain shift.
- Lightweight models showed limitations when faced with distributional variations in histopathological data.
Conclusions:
- Computationally efficient CNNs can aid high-throughput screening and clinical decision support for colorectal cancer.
- Robust clinical deployment necessitates multi-site validation to address data heterogeneity.
- Continued adaptation and development are required for reliable performance across diverse histopathological datasets.
